↓ Skip to main content

The Impact of Incremental Innovation in Biopharmaceuticals

Overview of attention for article published in PharmacoEconomics, February 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

policy
3 policy sources

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
15 Mendeley
Title
The Impact of Incremental Innovation in Biopharmaceuticals
Published in
PharmacoEconomics, February 2013
DOI 10.2165/00019053-200624002-00008
Pubmed ID
Authors

Ernst R. Berndt, Iain M. Cockburn, Karen A. Grépin

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 27%
Student > Doctoral Student 2 13%
Student > Ph. D. Student 2 13%
Other 1 7%
Lecturer > Senior Lecturer 1 7%
Other 3 20%
Unknown 2 13%
Readers by discipline Count As %
Social Sciences 3 20%
Business, Management and Accounting 2 13%
Nursing and Health Professions 2 13%
Medicine and Dentistry 2 13%
Economics, Econometrics and Finance 1 7%
Other 1 7%
Unknown 4 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2018.
All research outputs
#3,300,067
of 22,953,506 outputs
Outputs from PharmacoEconomics
#317
of 1,858 outputs
Outputs of similar age
#35,989
of 284,251 outputs
Outputs of similar age from PharmacoEconomics
#1
of 20 outputs
Altmetric has tracked 22,953,506 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,858 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,251 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.